A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

Clinical trial NCT01297309 · COMPLETED

Trial details

NCT number: NCT01297309
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypoparathyroidism

Start date: 2011-04-06
Primary completion: 2018-06-08
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.